Leeann M Ranieri, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 29 years
- Graduated 1997
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Leeann M Ranieri’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$22,311
Medicare paid this office $22,311 for 296 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 91 | $6,480 | $68 |
| Return visit (30+ min) | 78 | $4,509 | $54 |
| Short return visit (20+ min) | 57 | $3,337 | $56 |
| Short return visit (20+ min) | 36 | $1,714 | $44 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $961 | $87 |
See all 6 services
| Return visit (30+ min) | 91 | $6,480 | $68 |
| Return visit (30+ min) | 78 | $4,509 | $54 |
| Short return visit (20+ min) | 57 | $3,337 | $56 |
| Short return visit (20+ min) | 36 | $1,714 | $44 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $961 | $87 |
| Long return visit (40+ min) | 13 | $945 | $68 |
Who their Medicare patients are
296 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 12% · Women 66% · Also on Medicaid 22% · Health risk score 1.42. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 62% · Diabetes 27% · Coronary heart disease 25% · Depression 22% · Chronic kidney disease 20% · Cancer 19% · Atrial fibrillation 18% · Heart failure 16% · COPD 10% · Dementia 6% · Stroke 5%.
The office billed $119,746, Medicare allowed $32,175 and paid $22,311; for 350 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 296 | 350 | 73 | 1.42 | $119,746 | $22,311 |
| 2023 | 264 | 367 | 72 | 1.38 | $135,080 | $23,349 |
| 2022 | 330 | 406 | 75 | 1.42 | $157,482 | $28,282 |
| 2021 | 339 | 397 | 75 | 1.24 | $102,009 | $25,665 |
| 2020 | 362 | 597 | 75 | 0.98 | $54,881 | $30,794 |
| 2019 | 337 | 1,413 | 75 | 1.05 | $63,718 | $33,808 |
| 2018 | 363 | 742 | 75 | 0.96 | $62,311 | $38,759 |
| 2017 | 595 | 1,258 | 79 | 1.46 | $53,254 | $36,728 |
| 2016 | 439 | 843 | 78 | 1.29 | $38,406 | $25,364 |
| 2015 | 177 | 497 | 76 | 0.82 | $27,155 | $19,234 |
| 2013 | 29 | 48 | 68 | 1.42 | $5,074 | $1,455 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 131 | $8,986 | $58 |
| Long return visit (40+ min) | 41 | $4,467 | $91 |
| Short return visit (20+ min) | 83 | $4,359 | $49 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $1,693 | $77 |
2022: 8 services
| Return visit (30+ min) | 132 | $9,037 | $63 |
| Short return visit (20+ min) | 94 | $5,028 | $48 |
| Long return visit (40+ min) | 48 | $5,011 | $100 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $2,417 | $97 |
| Transitional care management services for problem of high complexity | 11 | $1,582 | $144 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 12 | $1,314 | $110 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,233 | $73 |
| Transitional care management services for problem of at least moderate complexity | 11 | $1,102 | $100 |
2021: 7 services
| Return visit (30+ min) | 90 | $7,036 | $76 |
| Return visit (30+ min) | 95 | $4,924 | $50 |
| Short return visit (20+ min) | 43 | $2,512 | $56 |
| Long return visit (40+ min) | 17 | $2,036 | $120 |
| Telephone medical discussion with physician, 21-30 minutes | 22 | $1,987 | $83 |
| Short return visit (20+ min) | 22 | $829 | $36 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 30 | $369 | $12 |
2020: 10 services
| Return visit (30+ min) | 212 | $14,325 | $59 |
| Influenza vaccine split virus, preservative free | 44 | $2,610 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,063 | $98 |
| Pneumococcal vaccine, 23-valent | 18 | $2,028 | $113 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 70 | $1,416 | $16 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,171 | $65 |
| Long return visit (40+ min) | 12 | $895 | $75 |
| Short return visit (20+ min) | 23 | $881 | $38 |
| Administration of influenza virus vaccine | 45 | $673 | $15 |
| Administration of pneumococcal vaccine | 26 | $379 | $15 |
2019: 9 services
| Return visit (30+ min) | 224 | $15,856 | $54 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $3,244 | $98 |
| Short return visit (20+ min) | 57 | $2,379 | $38 |
| Influenza vaccine split virus, preservative free | 30 | $1,639 | $55 |
| Pneumococcal vaccine, 23-valent | 13 | $1,436 | $110 |
| Long return visit (40+ min) | 16 | $1,290 | $81 |
| Administration of influenza virus vaccine | 29 | $471 | $16 |
| Administration of pneumococcal vaccine | 23 | $374 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 31 | $77 | $2 |
2018: 9 services
| Return visit (30+ min) | 276 | $22,584 | $59 |
| Short return visit (20+ min) | 84 | $3,717 | $38 |
| Pneumococcal vaccine, 13-valent | 11 | $2,174 | $198 |
| Pneumococcal vaccine, 23-valent | 16 | $1,689 | $106 |
| Influenza vaccine split virus, preservative free | 30 | $1,492 | $50 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $1,459 | $97 |
| Administration of influenza virus vaccine | 31 | $620 | $20 |
| Administration of pneumococcal vaccine | 27 | $540 | $20 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $252 | $13 |
2017: 8 services
| Return visit (30+ min) | 195 | $15,286 | $65 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 345 | $8,525 | $11 |
| Long return visit (40+ min) | 27 | $2,434 | $84 |
| Pneumococcal vaccine, 13-valent | 11 | $1,956 | $178 |
| Short return visit (20+ min) | 32 | $1,330 | $42 |
| Influenza vaccine split virus, preservative free | 21 | $953 | $45 |
| Administration of influenza virus vaccine | 21 | $524 | $25 |
| Administration of pneumococcal vaccine | 17 | $400 | $24 |
2016: 6 services
| Return visit (30+ min) | 120 | $9,147 | $61 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 238 | $5,649 | $13 |
| Short return visit (20+ min) | 89 | $3,529 | $36 |
| Pneumococcal vaccine, 13-valent | 17 | $2,962 | $174 |
| Long return visit (40+ min) | 16 | $1,026 | $64 |
| Administration of pneumococcal vaccine | 20 | $457 | $23 |
2015: 6 services
| Return visit (30+ min) | 101 | $7,930 | $67 |
| Short return visit (20+ min) | 86 | $4,678 | $45 |
| Pneumococcal vaccine, 13-valent | 19 | $2,885 | $152 |
| Influenza vaccine split virus, preservative free | 16 | $531 | $33 |
| Administration of pneumococcal vaccine | 17 | $306 | $18 |
| Administration of influenza virus vaccine | 14 | $248 | $18 |
2013: 1 service
| Short return visit (20+ min) | 13 | $440 | $31 |
Medicaid work
$110 in 2022
Medicaid paid $110 for 14 billed services this clinician did in 2022, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 14 | $110 |
| 2022 | 14 | 1 | 13 | $110 |
Drugs they prescribed that Part D paid
$17,852
Pharmacies billed $17,852 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
311 generic and fewer than 11 brand-name prescriptions · $17,852 in drug cost · 34 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Losartan | 27 | $187 | $7 |
| Fluticasone Propionate | 15 | $181 | $12 |
| Amlodipine Besylate | 22 | $134 | $6 |
| Tamsulosin | 11 | $130 | $12 |
| Metformin | 15 | $95 | $6 |
See all 7 drugs
| Losartan | 27 | $187 | $7 |
| Fluticasone Propionate | 15 | $181 | $12 |
| Amlodipine Besylate | 22 | $134 | $6 |
| Tamsulosin | 11 | $130 | $12 |
| Metformin | 15 | $95 | $6 |
| Atorvastatin | 25 | $94 | $4 |
| Levothyroxine | 14 | $82 | $6 |
Year by year
| 2024 | 347 | 146 | None | None | $17,852 |
| 2023 | 508 | 191 | 3% (14) | None | $47,048 |
| 2022 | 408 | 183 | 4% (17) | None | $39,620 |
| 2021 | 381 | 166 | None | 13% | $33,731 |
| 2020 | 760 | 146 | None | None | $67,426 |
| 2019 | 794 | 198 | None | None | $52,167 |
| 2018 | 902 | 220 | 1% (13) | 22% | $73,525 |
| 2017 | 424 | 158 | 4% (16) | None | $24,702 |
| 2016 | 641 | 165 | 3% (19) | None | $46,249 |
| 2015 | 1,181 | 218 | 2% (21) | 25% | $86,070 |
| 2014 | 1,257 | 172 | 3% (34) | 26% | $83,211 |
| 2013 | 843 | 182 | 4% (33) | None | $40,869 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Tamsulosin | 25 | $840 | $34 |
| Levothyroxine | 30 | $558 | $19 |
| Atorvastatin | 32 | $540 | $17 |
| Losartan | 22 | $454 | $21 |
| Amlodipine Besylate | 33 | $444 | $13 |
| Metformin | 15 | $245 | $16 |
| Lisinopril | 17 | $213 | $13 |
| Nitrofurantoin Mono-Macro | 11 | $165 | $15 |
| Gabapentin | 15 | $148 | $10 |
| Fluticasone Propionate | 14 | $144 | $10 |
2022: 10 drugs
| Rosuvastatin | 11 | $378 | $34 |
| Levothyroxine | 12 | $330 | $27 |
| Lisinopril | 22 | $305 | $14 |
| Gabapentin | 14 | $283 | $20 |
| Ondansetron Odt | 13 | $254 | $20 |
| Diclofenac | 12 | $250 | $21 |
| Atorvastatin | 19 | $150 | $8 |
| Amlodipine Besylate | 19 | $146 | $8 |
| Fluticasone Propionate | 11 | $105 | $10 |
| Losartan | 19 | $104 | $5 |
2021: 10 drugs
| Synthroid | 12 | $1,177 | $98 |
| Atorvastatin | 25 | $780 | $31 |
| Rosuvastatin | 14 | $503 | $36 |
| Levothyroxine | 23 | $474 | $21 |
| Simvastatin | 15 | $204 | $14 |
| Tamsulosin | 11 | $203 | $18 |
| Lisinopril | 21 | $195 | $9 |
| Amlodipine Besylate | 16 | $180 | $11 |
| Escitalopram | 12 | $107 | $9 |
| Metformin | 12 | $96 | $8 |
2020: 19 drugs
| Eliquis | 11 | $11,005 | $1,000 |
| Synthroid | 36 | $3,659 | $102 |
| Levothyroxine | 46 | $1,000 | $22 |
| Rosuvastatin | 14 | $997 | $71 |
| Atorvastatin | 50 | $772 | $15 |
| Pravastatin | 15 | $552 | $37 |
| Lisinopril | 47 | $384 | $8 |
| Simvastatin | 32 | $383 | $12 |
| Amlodipine Besylate | 32 | $327 | $10 |
| Tamsulosin | 16 | $326 | $20 |
| Losartan | 19 | $258 | $14 |
| Metformin | 28 | $245 | $9 |
| Chlorthalidone | 12 | $240 | $20 |
| Hydrochlorothiazide | 19 | $232 | $12 |
| Escitalopram | 16 | $192 | $12 |
| Benazepril | 12 | $191 | $16 |
| Omeprazole | 16 | $165 | $10 |
| Metoprolol | 21 | $164 | $8 |
| Pantoprazole | 12 | $147 | $12 |
2019: 17 drugs
| Synthroid | 34 | $3,150 | $93 |
| Estradiol | 20 | $2,808 | $140 |
| Levothyroxine | 75 | $1,448 | $19 |
| Atorvastatin | 64 | $903 | $14 |
| Losartan | 28 | $399 | $14 |
| Fluticasone Propionate | 26 | $326 | $13 |
| Hydrochlorothiazide | 25 | $321 | $13 |
| Pravastatin | 12 | $292 | $24 |
| Simvastatin | 30 | $291 | $10 |
| Amlodipine Besylate | 36 | $280 | $8 |
| Pantoprazole | 11 | $240 | $22 |
| Metoprolol | 19 | $213 | $11 |
| Metformin | 15 | $199 | $13 |
| Lisinopril | 24 | $168 | $7 |
| Fluoxetine | 19 | $127 | $7 |
| Prednisone | 13 | $94 | $7 |
| Omeprazole | 15 | $93 | $6 |
2018: 21 drugs
| Eliquis | 11 | $8,056 | $732 |
| Synthroid | 24 | $2,062 | $86 |
| Levothyroxine | 61 | $1,301 | $21 |
| Atorvastatin | 71 | $1,184 | $17 |
| Estradiol | 12 | $1,135 | $95 |
| Fluticasone Propionate | 40 | $735 | $18 |
| Fluoxetine | 22 | $563 | $26 |
| Losartan | 33 | $468 | $14 |
| Escitalopram | 16 | $444 | $28 |
| Lisinopril | 27 | $378 | $14 |
| Metformin | 31 | $362 | $12 |
| Amlodipine Besylate | 35 | $335 | $10 |
| Simvastatin | 29 | $315 | $11 |
| Hydrochlorothiazide | 37 | $301 | $8 |
| Pantoprazole | 16 | $231 | $14 |
| Metoprolol | 19 | $230 | $12 |
| Metoprolol | 11 | $212 | $19 |
| Allopurinol | 11 | $157 | $14 |
| Prednisone | 15 | $123 | $8 |
| Zolpidem | 12 | $94 | $8 |
| Citalopram Hbr | 19 | $79 | $4 |
2017: 11 drugs
| Synthroid | 16 | $791 | $49 |
| Levothyroxine | 35 | $744 | $21 |
| Metoprolol | 14 | $575 | $41 |
| Pravastatin | 13 | $526 | $40 |
| Tamsulosin | 11 | $369 | $34 |
| Atorvastatin | 20 | $285 | $14 |
| Fluticasone Propionate | 19 | $281 | $15 |
| Prednisone | 18 | $182 | $10 |
| Hydrochlorothiazide | 15 | $162 | $11 |
| Metformin | 12 | $125 | $10 |
| Escitalopram | 13 | $124 | $10 |
2016: 18 drugs
| Eliquis | 12 | $7,131 | $594 |
| Colchicine | 11 | $1,820 | $165 |
| Levothyroxine | 40 | $985 | $25 |
| Fluoxetine | 19 | $831 | $44 |
| Atorvastatin | 37 | $698 | $19 |
| Duloxetine | 15 | $601 | $40 |
| Pravastatin | 19 | $531 | $28 |
| Prednisone | 20 | $363 | $18 |
| Fluticasone Propionate | 23 | $323 | $14 |
| Amlodipine Besylate | 18 | $282 | $16 |
| Potassium Chloride | 14 | $276 | $20 |
| Atenolol | 16 | $215 | $13 |
| Simvastatin | 20 | $200 | $10 |
| Lisinopril | 13 | $197 | $15 |
| Metformin | 11 | $182 | $17 |
| Hydrochlorothiazide | 11 | $142 | $13 |
| Losartan | 13 | $119 | $9 |
| Estradiol | 13 | $68 | $5 |
2015: 27 drugs
| Victoza 2-Pak | 17 | $9,885 | $581 |
| Exelon | 11 | $4,703 | $428 |
| Premarin | 12 | $3,279 | $273 |
| Uloric | 12 | $3,020 | $252 |
| Prempro | 11 | $1,441 | $131 |
| Levothyroxine | 80 | $1,409 | $18 |
| Atorvastatin | 85 | $1,380 | $16 |
| Fluoxetine | 45 | $888 | $20 |
| Proair Hfa | 14 | $795 | $57 |
| Estradiol | 28 | $653 | $23 |
| Fenofibrate | 13 | $579 | $45 |
| Metoprolol | 12 | $563 | $47 |
| Bupropion Xl | 14 | $502 | $36 |
| Valacyclovir | 12 | $406 | $34 |
| Doxycycline Monohydrate | 12 | $386 | $32 |
| Fluticasone Propionate | 44 | $341 | $8 |
| Simvastatin | 56 | $336 | $6 |
| Montelukast | 14 | $309 | $22 |
| Lisinopril | 38 | $275 | $7 |
| Allopurinol | 12 | $232 | $19 |
| Potassium Chloride | 14 | $182 | $13 |
| Omeprazole | 15 | $177 | $12 |
| Metformin | 25 | $176 | $7 |
| Metoprolol | 15 | $173 | $12 |
| Amlodipine Besylate | 33 | $164 | $5 |
| Mirtazapine | 12 | $115 | $10 |
| Ranitidine | 11 | $99 | $9 |
2014: 30 drugs
| Benicar | 11 | $5,045 | $459 |
| Spiriva | 11 | $4,787 | $435 |
| Premarin | 14 | $2,964 | $212 |
| Levothyroxine | 103 | $1,556 | $15 |
| Ibandronate | 12 | $1,346 | $112 |
| Atorvastatin | 60 | $1,135 | $19 |
| Bupropion Xl | 13 | $946 | $73 |
| Synthroid | 15 | $571 | $38 |
| Fenofibrate | 11 | $517 | $47 |
| Simvastatin | 54 | $472 | $9 |
| Montelukast | 17 | $435 | $26 |
| Lisinopril | 58 | $365 | $6 |
| Omeprazole | 16 | $313 | $20 |
| Quetiapine | 12 | $295 | $25 |
| Fluticasone Propionate | 25 | $283 | $11 |
| Amlodipine Besylate | 38 | $272 | $7 |
| Ipratropium | 13 | $260 | $20 |
| Metformin | 35 | $225 | $6 |
| Estradiol | 17 | $225 | $13 |
| Clopidogrel | 13 | $223 | $17 |
| Fluoxetine | 18 | $214 | $12 |
| Methylprednisolone | 11 | $212 | $19 |
| Zolpidem | 27 | $187 | $7 |
| Lovastatin | 13 | $125 | $10 |
| Tramadol | 18 | $78 | $4 |
| Topiramate | 12 | $78 | $6 |
| Alprazolam | 17 | $77 | $5 |
| Ciprofloxacin | 17 | $74 | $4 |
| Cephalexin | 13 | $65 | $5 |
| Furosemide | 13 | $46 | $4 |
2013: 23 drugs
| Diovan | 15 | $2,157 | $144 |
| Doxycycline Hyclate | 15 | $606 | $40 |
| Fluticasone Propionate | 24 | $528 | $22 |
| Synthroid | 12 | $508 | $42 |
| Levothyroxine | 47 | $397 | $8 |
| Montelukast | 14 | $394 | $28 |
| Simvastatin | 33 | $294 | $9 |
| Atorvastatin | 13 | $275 | $21 |
| Omeprazole | 16 | $256 | $16 |
| Acetaminophen-Codeine | 11 | $227 | $21 |
| Methylprednisolone | 11 | $223 | $20 |
| Clopidogrel | 13 | $173 | $13 |
| Hydrocodone-Acetaminophen | 14 | $141 | $10 |
| Lisinopril | 25 | $140 | $6 |
| Triamterene-Hctz | 15 | $134 | $9 |
| Metoprolol | 20 | $120 | $6 |
| Amlodipine Besylate | 13 | $113 | $9 |
| Zolpidem | 17 | $110 | $6 |
| Citalopram Hbr | 15 | $67 | $4 |
| Metformin | 11 | $59 | $5 |
| Lorazepam | 11 | $56 | $5 |
| Hydrochlorothiazide | 17 | $51 | $3 |
| Ciprofloxacin | 11 | $51 | $5 |
Professional record
- NPI
- 1043202427
- Licence
- CA 95014829
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LP2300X (363LP2300X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2005-08-22
- NPI last updated
- 2025-12-31
- NPI record certified
- 2025-12-31
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 13400 E Shea Blvd, Scottsdale, AZ, 85259